The movie theater ticket subscription service MoviePass is back, with the company set to relaunch in beta form on Labor Day.
MORE: Lou Trailer Previews the Allison Janney-led Action Thriller
Since buying back the company late last year, MoviePass cofounder Stacy Spikes and his team have been working on relaunching the subscription service. According to the company (via Insider), MoviePass will open a waitlist for users to sign up for the beta version beginning on Thursday at 9 a.m. EST.
The waitlist will be open for five days and will be on a first come, first served basis, with just an email address and zip code required for signing up. Once the waitlist closes, users who are chosen for the service will be notified on Labor Day (September 5, 2022), and will be offered three price tiers to choose from.
While pricing may vary, Insider reports that the general pricing will be either $10, $20, or $30 a month. Each subscription option will give users a select amount of credits to use each month to see movies. As of now, there will be no “unlimited” option in the beta, although it’s unknown if that will appear down the line.
Similar to the previous way MoviePass operated, users who are chosen will be able to order movie tickets — MoviePass says it has partnerships with 25% of theaters in the United States — through the app or via their MoviePass card, which will now be black instead of the former red and will operate similarly to a MasterCard debit card.
Originally founded in 2011, MoviePass allowed users to check into a movie and showtime, and then purchase a ticket using a debit card that was pre-loaded with the funds of the ticket.
MORE: New Sing-Along Versions of Frozen & Frozen 2 Set for Disney+ Day
The service quickly became a massive success following its launch, changing the movie landscape in terms of ticketing and paving the way for other theater chains to later introduce their own subscription ticketing services. The service ran into financial issues by 2018, however, and was shut down in 2020 after its parent company filed for bankruptcy.
